News &

Press

venBio news

“venBio Raises $528 Million Venture Capital Fund Focused on Life Science Companies.”

“venBio Raises $550 Million Venture Capital Fund Focused on Life Sciences.”

“venBio Closes $394 Million Life Sciences Venture Capital Fund.”

Portfolio news

Harmony Biosciences reports fourth quarter and full year 2022 financial results and business updates

Feb 22, 2023

Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Feb 18, 2023

FDA Approves SYFOVRE™ (pegcetacoplan injection) as the First and Only Treatment for Geographic Atrophy (GA), a Leading Cause of Blindness

Feb 17, 2023

ImmPACT Bio Appoints Biren Amin, M.B.A. to its Board of Directors

Feb 8, 2023

ImmPACT Bio Announces FDA Clearance of IND for Novel Bispecific CAR to Treat Aggressive B-cell Lymphoma

Feb 3, 2023

Artiva Biotherapeutics Receives FDA Fast Track Designation for AB-101

Jan 31, 2023

Tallac Therapeutics Appoints Kevin N. Heller, M.D., as Chief Medical Officer

Jan 24, 2023

San Francisco office

1700 Owens Street, Suite 595
San Francisco, CA 94158

Seattle office

1200 Westlake Ave N, Suite 900
Seattle, WA 98109

© 2024 venBio. All Rights Reserved.